| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |